Skip to main content

Clinical aspects of lipoprotein disorders

  • Chapter
Atherosclerosis and Cardiovascular Diseases
  • 78 Accesses

Abstract

Familial chylomicronemia (type I hyperlipoproteinemia) is a rare genetic disease due to the absence of the lipoprotein lipase activity. This genetic error involves either the extrahepatic lipoprotein lipase (lipoprotein lipase deficiency) or its obligatory co-factor, i.e. the apoprotein C-II (apo C-II deficiency). The clinical features of this disease, wich is usually diagnosed in infancy or childood, are hepatosplenomegaly, recurrent abdominal pain, pancreatitis, eruptive xanthomata and lipemia retinalis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fellin, R, Baggio, G, Poli, A, Augustin, J, Baiocchi, MR, Baldo, G, Sinigaglia, M, Greten, H, Crepaldi, G (1983). Familial lipoprotein lipase and apolipoprotein C-II deficiency. Atherosclerosis, 49, 55

    Article  PubMed  CAS  Google Scholar 

  2. Manzato, E, Marin, R, Gasparotto, A, Baggio, G, Fellin, R, Crepaldi, G (1984). The plasma lipoproteins in familial chylomicronemia. J Lab Clin Med, 104, 778

    PubMed  CAS  Google Scholar 

  3. Baggio, G, Manzato, E, Gabelli, C, Fellin, R, Martini, S, Baldo-Enzi, G, Verlato, F, Baiocchi, MR, Sprecher, DL, Kashyap, ML, Brewer, HB, Crepaldi, G (1986). Apolipoprotein C-II deficiency syndrome. J Clin Invest, 77, 520

    Article  PubMed  CAS  Google Scholar 

  4. Fojo, SS, Law, SW, Sprecher, DL, Gregg, RE, Baggio, G, Brewer, HB (1984). Analysis of the apo C-II gene in apo C-II deficient patients. Biochem Biophys Res Commun, 124, 308

    Article  PubMed  CAS  Google Scholar 

  5. Humphries, SE, Williams, L, Myklebost, O, Stalenhoef, AFH, Demacker, PNM, Baggio, G, Crepaldi, G, Galton, DJ, Williamson, R (1984). Familial apolipoprotein CII deficiency: a preliminary analysis of the gene defect in two independent families. Hum Genet, 67, 151

    Article  PubMed  CAS  Google Scholar 

  6. Beaumont, JL, Carlson, LA, Cooper, GR, Fejfar, Z, Fredrickson, DS, Strasser, T (1970). Classification of hyperlipidaemias and hyperlipoproteinemias. In: Bull Wld Hlth 43: 891–53.

    CAS  Google Scholar 

  7. Crepaldi, G, Fellin, R, Briani, G, Baggio, G, Manzato, E, Veronese, R (1977). Prevalence of coronary artery disease and peripheral artery disease in patients with different types of primary hyperlipidemia. Atherosclerosis, 26, 593

    Article  CAS  Google Scholar 

  8. Manzato, E, Pagnan, A, Ziron, L, Gasparotto, A, Braggion, M (1984). Double pre-beta lipoprotein. Isolation and characterization of the two population of very low density lipoproteins by zonal ultracentrifugation. Arteriosclerosis, 4, 598

    Article  PubMed  CAS  Google Scholar 

  9. Manzato, E, Gasparotto, A, Marin, R, Baggio, G, Baldo, G, Crepaldi, G (1984). Characterization with zonal ultracentrifugation of low-density lipoproteins in type V hyperlipoproteinemia. Biochim Biophys Acta, 793, 365

    PubMed  CAS  Google Scholar 

  10. Manzato, E, Marin, R, Gasparotto, A, Baggio, G, Martini, S, Gabelli, C, Crepaldi, G (1986). Lipoprotein modifications during dietary treatment in patients with primary type V hyperlipoproteinaemia. Europ J Clin Invest, 16, 149

    Article  PubMed  CAS  Google Scholar 

  11. Manzato, E, Fellin, R, Baggio, G, Walch, S, Neubeck, W, Seidel, D (1976). Formation of lipoprotein-X. Its relationship to bile compounds. J Clin Invest, 57, 1248

    Article  PubMed  CAS  Google Scholar 

  12. Baggio, G, Muller, P, Wieland, H, Niedmann, PD, Seidel, D (1978). Influence of bile acids and free fatty acids on physicochemical properties of LP-X. Res Exp Med 172, 211

    Article  CAS  Google Scholar 

  13. Fellin, R, Manzato, E, Zotti, S, Baggio, G, Briani, G, Rugge, M (1978). Lipoprotein-X and diagnosis of cholestasis: comparison with other biochemical parameters and liver biopsy. Clin Chim Acta, 85, 41

    Article  PubMed  CAS  Google Scholar 

  14. Fedele, D, Fellin, R, Lapolla, A, Baggio, G, De Romedi, F, Frigato, F, Crepaldi, G (1982). Serum lipid and lipoprotein levels and metabolic control in insulin-treated diabetics. Acta Diabetol Lat, 19, 151

    Article  PubMed  CAS  Google Scholar 

  15. Fedele, D, Tiengo, A, Bertotti, P, Crepaldi, G (1982). Macroangiopatia e parametri clinico-metabolici nella malattia diabetica. Studio retrospettivo su 349 diabetici ricoverati in ambiente ospedaliero. Giorn Arterioscl, 7, 277

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 MTP Press Limited

About this chapter

Cite this chapter

Crepaldi, G. et al. (1987). Clinical aspects of lipoprotein disorders. In: Lenzi, S., Descovich, G.C. (eds) Atherosclerosis and Cardiovascular Diseases. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3205-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-3205-0_12

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7938-9

  • Online ISBN: 978-94-009-3205-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics